These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 18446711
1. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. Cottone S, Lorito MC, Riccobene R, Nardi E, Mulè G, Buscemi S, Geraci C, Guarneri M, Arsena R, Cerasola G. J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711 [Abstract] [Full Text] [Related]
2. [Inflammation, oxidative stress and kidney function in arterial hypertension]. Cerasola G, Guarneri M, Cottone S. G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813 [Abstract] [Full Text] [Related]
3. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients. Cottone S, Mulè G, Guarneri M, Palermo A, Lorito MC, Riccobene R, Arsena R, Vaccaro F, Vadalà A, Nardi E, Cusimano P, Cerasola G. Nephrol Dial Transplant; 2009 Feb; 24(2):497-503. PubMed ID: 18772174 [Abstract] [Full Text] [Related]
4. [Cardiovascular system in patients in different stages of chronic kidney disease]. Strózecki P, Kozłowski M, Grajewska M, Kurowski R, Stefańska A, Odrowaź-Sypniewska G, Serafin Z, Lasek W, Nartowicz E, Kubica J, Manitius J. Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094 [Abstract] [Full Text] [Related]
5. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease. Dummer CD, Thome' FS, Zingano B, Lindoso A, Veronese FV. J Nephrol; 2008 Aug; 21(6):900-8. PubMed ID: 19034875 [Abstract] [Full Text] [Related]
7. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease. Roberts MA, Hare DL, Ratnaike S, Ierino FL. Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208 [Abstract] [Full Text] [Related]
8. Cellular senescence, cardiovascular risk, and CKD: a review of established and hypothetical interconnections. Tsirpanlis G. Am J Kidney Dis; 2008 Jan; 51(1):131-44. PubMed ID: 18155543 [Abstract] [Full Text] [Related]
9. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Himmelfarb J. Semin Dial; 2004 Jan; 17(6):449-54. PubMed ID: 15660575 [Abstract] [Full Text] [Related]
11. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Himmelfarb J. Semin Dial; 2009 Dec; 22(6):636-43. PubMed ID: 20017834 [Abstract] [Full Text] [Related]
12. Vascular disease and chronic renal failure: new insights. Nanayakkara PW, Gaillard CA. Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816 [Abstract] [Full Text] [Related]
13. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Moinuddin I, Leehey DJ. Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113 [Abstract] [Full Text] [Related]
14. What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention. Del Vecchio L, Locatelli F, Carini M. Semin Dial; 2011 Jan; 24(1):56-64. PubMed ID: 21299632 [Abstract] [Full Text] [Related]
15. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling. Naito K, Anzai T, Yoshikawa T, Anzai A, Kaneko H, Kohno T, Takahashi T, Kawamura A, Ogawa S. J Card Fail; 2008 Dec; 14(10):831-8. PubMed ID: 19041046 [Abstract] [Full Text] [Related]
16. Endothelial function, CRP and oxidative stress in chronic kidney disease. Annuk M, Soveri I, Zilmer M, Lind L, Hulthe J, Fellström B. J Nephrol; 2005 Dec; 18(6):721-6. PubMed ID: 16358230 [Abstract] [Full Text] [Related]
17. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease? Rubin C, Nolin TD, Himmelfarb J. Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962 [Abstract] [Full Text] [Related]
18. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F. Nefrologia; 2008 Nov; 28 Suppl 3():39-48. PubMed ID: 19018737 [Abstract] [Full Text] [Related]
19. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)]. Minami J, Ishimitsu T, Sudo Y, Matsuoka H. Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391 [Abstract] [Full Text] [Related]
20. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Gusbeth-Tatomir P, Covic A. Kidney Blood Press Res; 2007 Sep; 30(2):97-107. PubMed ID: 17374960 [Abstract] [Full Text] [Related] Page: [Next] [New Search]